EdgarLookup

abrdn Silver ETF Trust — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that abrdn Silver ETF Trust filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
52.2%
Return on Assets
Net income ÷ assets
0x
Debt-to-Equity
Total liabilities ÷ equity

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 ($163.0K) Feb 28, 2014
FY2012 Dec 31, 2012 $196.0K Feb 28, 2013
FY2011 Dec 31, 2011 $609.4K Mar 7, 2012
FY2011 Dec 31, 2010 $81.3K Mar 7, 2012
FY2011 Dec 31, 2009 $27.5K Mar 7, 2012

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.84B Mar 3, 2026
FY2025 Dec 31, 2024 $215.24M Mar 3, 2026
FY2025 Dec 31, 2023 ($13.38M) Mar 3, 2026
FY2024 Dec 31, 2022 $6.28M Feb 28, 2025
FY2023 Dec 31, 2021 ($143.27M) Feb 29, 2024
FY2022 Dec 31, 2020 $261.21M Mar 1, 2023
FY2021 Dec 31, 2019 $56.42M Sep 29, 2022
FY2020 Dec 31, 2018 ($28.16M) Mar 1, 2021
FY2019 Dec 31, 2017 $12.22M Feb 28, 2020
FY2018 Dec 31, 2016 $39.35M Mar 1, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Feb 29, 2016
FY2014 Dec 31, 2012 $0 Mar 2, 2015
FY2013 Dec 31, 2011 $0 Feb 28, 2014
FY2012 Dec 31, 2010 $0 Feb 28, 2013
FY2011 Dec 31, 2009 $0 Mar 7, 2012

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.43B Mar 3, 2026
FY2025 Dec 31, 2024 $1.42B Mar 3, 2026
FY2024 Dec 31, 2023 $1.06B Feb 28, 2025
FY2023 Dec 31, 2022 $1.12B Feb 29, 2024
FY2022 Dec 31, 2021 $995.41M Mar 1, 2023
FY2021 Dec 31, 2020 $863.88M Sep 29, 2022
FY2020 Dec 31, 2019 $418.94M Mar 1, 2021
FY2019 Dec 31, 2018 $339.82M Feb 28, 2020
FY2018 Dec 31, 2017 $351.14M Mar 1, 2019
FY2017 Dec 31, 2016 $311.35M Feb 27, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.37M Mar 3, 2026
FY2025 Dec 31, 2024 $366.0K Mar 3, 2026
FY2024 Dec 31, 2023 $271.0K Feb 28, 2025
FY2023 Dec 31, 2022 $280.0K Feb 29, 2024
FY2022 Dec 31, 2021 $253.0K Mar 1, 2023
FY2021 Dec 31, 2020 $220.0K Sep 29, 2022
FY2020 Dec 31, 2019 $11.47M Mar 1, 2021
FY2019 Dec 31, 2018 $88.0K Feb 28, 2020
FY2018 Dec 31, 2017 $89.0K Mar 1, 2019
FY2017 Dec 31, 2016 $79.0K Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.43B Mar 3, 2026
FY2025 Dec 31, 2024 $1.42B Mar 3, 2026
FY2025 Dec 31, 2023 $1.06B Mar 3, 2026
FY2025 Dec 31, 2022 $1.12B Mar 3, 2026
FY2024 Dec 31, 2021 $995.15M Feb 28, 2025
FY2023 Dec 31, 2020 $863.66M Feb 29, 2024
FY2022 Dec 31, 2019 $407.46M Mar 1, 2023
FY2021 Dec 31, 2018 $339.73M Sep 29, 2022
FY2020 Dec 31, 2017 $351.05M Mar 1, 2021
FY2019 Dec 31, 2016 $311.27M Feb 28, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Feb 29, 2016
FY2015 Dec 31, 2012 ($41.88M) Feb 29, 2016
FY2014 Dec 31, 2011 ($18.27M) Mar 2, 2015
FY2013 Dec 31, 2010 ($173.98M) Feb 28, 2014
FY2012 Dec 31, 2009 ($16.84M) Feb 28, 2013
FY2011 Jul 19, 2009 $0 Mar 7, 2012

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2013 $0 Feb 29, 2016
FY2015 Dec 31, 2012 $0 Feb 29, 2016
FY2014 Dec 31, 2011 $0 Mar 2, 2015
FY2013 Dec 31, 2010 $0 Feb 28, 2014
FY2012 Dec 31, 2009 $0 Feb 28, 2013
FY2011 Jul 19, 2009 $0 Mar 7, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 47 Mar 3, 2026
FY2025 Dec 31, 2024 4 Mar 3, 2026
FY2025 Dec 31, 2023 0 Mar 3, 2026
FY2024 Dec 31, 2022 0 Feb 28, 2025
FY2023 Dec 31, 2021 (3) Feb 29, 2024
FY2022 Dec 31, 2020 8 Mar 1, 2023
FY2021 Dec 31, 2019 2 Sep 29, 2022
FY2020 Dec 31, 2018 (1) Mar 1, 2021
FY2019 Dec 31, 2017 0 Feb 28, 2020
FY2018 Dec 31, 2016 2 Mar 1, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 79.25M Mar 3, 2026
FY2025 Dec 31, 2024 51.50M Mar 3, 2026
FY2024 Dec 31, 2023 46.55M Feb 28, 2025
FY2023 Dec 31, 2022 48.65M Feb 29, 2024
FY2022 Dec 31, 2021 44.75M Mar 1, 2023
FY2021 Dec 31, 2020 33.75M Sep 29, 2022
FY2020 Dec 31, 2019 23.30M Mar 1, 2021
FY2019 Dec 31, 2018 22.60M Feb 28, 2020
FY2018 Dec 31, 2017 21.35M Mar 1, 2019
FY2017 Dec 31, 2016 19.60M Feb 27, 2018